Ningbo Tianyi Medical Instrument Co., Ltd
Online roadshow announcement of initial public offering and listing on GEM
Sponsor (lead underwriter): Guotai Junan Securities Co.Ltd(601211)
The application of Ningbo Tianyi medical device Co., Ltd. (hereinafter referred to as “the issuer”, “Tianyi medical” and “the company”) for the initial public offering of 14736842 ordinary shares (A shares) (hereinafter referred to as “this offering”) has been examined and approved by the members of the gem listing committee of Shenzhen Stock Exchange, It has been approved to register by China Securities Regulatory Commission (hereinafter referred to as “CSRC”) (zjxk [2021] No. 3939).
This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as “strategic placement”) (if any), offline inquiry placement to qualified investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-share shares or non restricted depositary receipts market value in Shenzhen market (hereinafter referred to as “online issuance”).
This offering does not arrange strategic placement to the asset management plan of the issuer’s senior managers and core employees and other external investors. For example, the offering price exceeds the median and weighted average of offline investors’ quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic endowment insurance fund established through public offering after excluding the highest quotation For the enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, whichever is lower, the relevant subsidiaries of the sponsor will participate in the strategic placement of this issuance in accordance with the relevant provisions. The issuer and the sponsor (lead underwriter) will disclose the total amount of shares, the number of subscriptions, the proportion in the number of shares issued this time and the holding period in the announcement on the initial public offering of Ningbo Tianyi Medical Devices Co., Ltd. and its listing on the gem (hereinafter referred to as the “issuance announcement”).
This public offering has 14736842 shares, accounting for 25% of the total share capital after issuance, and the total share capital after this public offering is 58947368 shares. The initial number of strategic placement shares issued in this issuance is 736842 shares, accounting for 5% of this issuance, which is only composed of follow-up investment (if any) of relevant subsidiaries of the sponsor. The difference between the final placement quantity and the initial placement quantity of strategic investors is transferred back to offline issuance.
Before the launch of the callback mechanism, the initial offline issuance of this issuance was 9.8 million shares, accounting for 70.00% of the issuance after deducting the initial strategic placement; The initial number of shares issued online was 4.2 million, accounting for 30.00% of the number issued after deducting the initial strategic placement. The total quantity of final offline and online issuance is the total quantity of this issuance minus the final strategic placement quantity. The final offline and online issuance quantity will be determined according to the call back situation. The final offline and online issuance quantity and strategic placement (if any) will be specified in the announcement on initial public offering of shares and preliminary placement results of offline issuance of Ningbo Tianyi Medical Devices Co., Ltd. listed on GEM published on March 25, 2022 (T + 2).
In order to facilitate public investors to understand the issuer’s basic situation, development prospects and relevant arrangements for subscription of this issuance, the issuer and the sponsor (lead underwriter) will hold an online roadshow on this issuance.
1. Online roadshow time: 14:00-17:00 on March 22, 2022 (t-1);
2. Online roadshow website: panorama (website: http://rs.p5w.net. ）；
3. Participants: key members of the issuer’s management and relevant personnel of the sponsor (lead underwriter).
Investors who intend to participate in this subscription should read the website designated by the CSRC on March 15, 2022 (T-6) (cninfo, www.cn. Info. Com. CN; CSI, www.cs. Com. CN; China Securities, www.cn. Stock. Com; securities times, www.stcn. Com; Securities Daily, www.zqrb. Cn) The full text of the prospectus and relevant information on.
Please pay attention to it.
Issuer: sponsor (lead underwriter) of Ningbo Tianyi medical device Co., Ltd.: Guotai Junan Securities Co.Ltd(601211) March 21, 2022
(there is no text on this page, which is the seal page of the online roadshow announcement of Ningbo Tianyi medical device Co., Ltd. on initial public offering and listing on the GEM)
Ningbo Tianyi Medical Instrument Co., Ltd. date:
(there is no text on this page, which is the seal page of the online roadshow announcement of Ningbo Tianyi medical device Co., Ltd. on initial public offering and listing on the GEM)
Guotai Junan Securities Co.Ltd(601211) mm / DD / yyyy
